SLOW SODIUM Coated tablets (2015)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
Slow Sodium.
Qualitative and quantitative composition
The active ingredient is Sodium Chloride Ph.Eur. Sodium Chloride contains not less than 99.0 per cent and not more than 100.5 per cent of NaCl. One coated tablet contains 600 mg sodium chloride.
Pharmaceutical form
Coated tablets.
Therapeutic indications
For the treatment and prophylaxis of sodium chloride deficiency.
Posology and method of administration
It is important that the tablets should be swallowed whole with water (approx. 70ml per tablet where kidney function is normal to avoid hypernatraemia), and not chewed. <u>Adults:</u> For prophylaxis 4-8 ...
Contraindications
Slow Sodium is contra-indicated in any situation where salt retention is undesirable, such as oedema, heart disease, cardiac decompensation and primary or secondary aldosteronism; or where therapy is being ...
Special warnings and precautions for use
Warnings: None. Precautions Use of Slow Sodium without adequate water supplementation can produce hypernatraemia. The matrix (ghost) is often eliminated intact and owing to the risk of obstruction Slow ...
Interaction with other medicinal products and other forms of interaction
In hypertensive patients with chronic renal failure Slow Sodium may tend to impair the efficacy of antihypertensive drugs.
Fertility, pregnancy and lactation
As with most medicines, consult your doctor first if you are pregnant or breastfeeding.
Effects on ability to drive and use machines
Nil.
Undesirable effects
No side effects have been reported with Slow Sodium at the recommended dosage. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product ...
Overdose
Signs and symptoms Excessive intake of sodium chloride can result in hypernatraemia. Symptoms of hypernatraemia include restlessness, weakness, thirst, reduced salivation and lachrymation, swollen tongue, ...
Pharmacodynamic properties
Mode of action Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues, changes in osmotic tension influence the movement of fluids and diffusion of salts ...
Pharmacokinetic properties
Sodium chloride is readily absorbed from the gastro-intestinal tract. It is present in all body fluids but specially in the extracellular fluid. The amount of sodium lost (as sweat) is normally small. ...
Preclinical safety data
No information available.
List of excipients
Cetostearyl alcohol Gelatin Magnesium stearate Tablet coating Hypromellose phthalate (E464) Hydroxypropyl cellulose (E463) Talc Titanium dioxide (E171)
Incompatibilities
None known.
Shelf life
Five years.
Special precautions for storage
Protect from moisture and store below 30°C. The tablets should be dispensed in moisture proof containers. Medicines should be kept out of reach of children.
Nature and contents of container
The tablets are available in containers of 100 tablets.
Special precautions for disposal and other handling
None.
Marketing authorization holder
HK Pharma Ltd, PO BOX 845, BEDFORD, MK45 9EB
Marketing authorization number(s)
PL 16784/0003
Date of first authorization / renewal of the authorization
28 April 1998
Date of revision of the text
July 2015
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
